StonvexLoading…
StonvexStonvexStonvexCore line items from TENB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $262.06M | $999.40M | $738.87M | $486.43M |
Operating Income | $8.76M | $-9.17M | $-18.02M | $-25.16M |
Net Income | $1.41M | $-36.12M | $-35.38M | $-37.64M |
EPS (Diluted) | $0.01 | $-0.30 | $-0.29 | $-0.31 |
Total Assets | $1.62B | $1.75B | $1.65B | $1.66B |
Total Liabilities | $1.37B | $1.42B | $1.31B | $1.31B |
Cash & Equivalents | $139.19M | $187.76M | $171.85M | $175.03M |
Free Cash Flow OCF − CapEx | $85.38M | $254.65M | $171.95M | $118.97M |
Shares Outstanding | 117.69M | 120.12M | 120.52M | 120.53M |